G. J., Williams, A. W., Badley, A. D.,Halamka, J., Virk, A., Swift, M. D., Wagner, T., & Soundararajan, V.(n.d.). Real-world effectiveness of Ad26.COV2.S adenoviral vectorvaccine for COVID-19. 18.
et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111.
[2] Schrag SJ, Verani JR, Dixon BE, et al. Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of delta and omicron variant predominance in the United States. JAMA Netw Open 2022; 5: e2233273–73. [3] Prasad S, Kalafat E, ...
COVID-19在美国的突变可能使其产生抗药性 New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. One was first discovered in Britain and South Africa.新的研究表...
四川大学华西医院李为民/陈蕾/刘丹团队在知名期刊Signal Transduction and Targeted Therapy(IF= 39.3,JCR分区一区)在线发表题为“Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vacci...
It is critically important to understand the vaccine effectiveness (VE) of COVID-19 vaccines among IC populations as recommendations are updated over time in response to the evolving COVID-19 pandemic. Areas covered A targeted literature review was conducted to identify real-world studies that ...
COVID-19 vaccine trackerand landscape. (n.d.). Retrieved June6, 2021, from https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Landscape ofobservational study designs on the effectiveness of COVID-19 vaccination.(n.d.). Retrieved June 6, 2021, from http...
3)vaccine effectiveness(疫苗保护能力) ——在英国:相对阿尔法接种1剂后对症状性感染的有效性降低; ——疫苗在预防住院方面仍然有效; ——加拿大的大部分德尔塔病例患者是未接种或未完全接种者 注:英国公共卫生局。正在关注和研究的SARS-CoV-2变种病毒 截至6月24日, 加拿大全国各个省和区内合格人群(≥12岁) 至少...
3)vaccine effectiveness(疫苗保护能力) ——在英国:相对阿尔法接种1剂后对症状性感染的有效性降低; ——疫苗在预防住院方面仍然有效; ——加拿大的大部分德尔塔病例患者是未接种或未完全接种者 注:英国公共卫生局。正在关注和研究的SARS-CoV-2变种病毒
2024年2月14日,四川大学华西医院李为民/陈蕾/刘丹团队在知名期刊Signal Transduction and Targeted Therapy(IF= 39.3,JCR分区一区)在线发表题为“Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines...